Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
BMJ Case Rep ; 15(8)2022 Aug 26.
Article in English | MEDLINE | ID: mdl-36028242

ABSTRACT

A toddler presented with melaena on a background of a possible enteric duplication cyst, diagnosed in the neonatal period which 'vanished'. What was later confirmed to be a small bowel duplication cyst was not seen on follow-up ultrasounds and thus the patient was managed expectantly until presentation as an emergency. Our case highlights the challenges faced in managing cystic abdominal structures in infancy and the potential consequences of expectant management. We discuss whether cross-sectional imaging or diagnostic laparoscopy should be advocated when duplications cysts are considered amongst the differentials of a lesion on ultrasound.


Subject(s)
Cysts , Digestive System Abnormalities , Laparoscopy , Humans , Infant, Newborn , Melena , Ultrasonography
2.
Histopathology ; 80(5): 752-761, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34792803

ABSTRACT

A number of randomised controlled trials (RCT) have compared different techniques to improve lymph node yield (LNY) in colorectal cancer specimens, but data on comparative effectiveness are sparse. Our aim was to compare the relative effectiveness and rank all available techniques. A systematic search of Embase, Cochrane, PubMed and Scopus was performed for randomised trials. Pairwise was meta-analysis performed if more than two homogeneous studies were available for each comparison. Network meta-analysis was used to rank and compare all available techniques. Fifteen studies fulfilled the inclusion criteria. Techniques that were compared included methylene blue (MB), glacial acetic acid, ethanol, distilled water and formaldehyde (GEWF), Carnoy solution (CS), patent blue (PB), formalin, fat clearing (FC) and their combinations. The overall quality of studies was found to be fair. In pairwise meta-analysis MB had a higher lymph node yield weighted mean difference (WMD) = 13.67 (4.83-22.51), P < 0.01, lower number of specimens with fewer than 12 lymph nodes log odds ratio = -1.88 (-2.8, -0.91), P < 0.01 and higher LNY in patients with prior chemoradiotherapy [WMD = 9.11 (3.15, 15.08), P = 0.02] compared to formalin. Evaluation of the network plot revealed a well-connected network. In network meta-analysis MBFC had a higher LNY with [mean difference (MD) 13 and 95% credible interval (CrI) = 2.09-23.91] compared to formalin. MBFC probability of being the best technique for LNY was 91.4%. In network meta-analysis MB did not have a statistically significant difference when compared to formalin. MBFCS seems to be the most effective technique for LNY. Further studies are required to make safe conclusions for outcomes such positive lymph nodes and upstaging.


Subject(s)
Biopsy/methods , Colorectal Neoplasms/pathology , Lymph Node Excision/methods , Lymph Nodes/pathology , Acetic Acid , Chemoradiotherapy , Chloroform , Colorectal Neoplasms/therapy , Coloring Agents , Comparative Effectiveness Research , Ethanol , Formaldehyde , Humans , Lymphatic Metastasis , Methylene Blue , Neoplasm Staging/methods , Network Meta-Analysis , Rosaniline Dyes
4.
Eur J Gastroenterol Hepatol ; 24(7): 857-9, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22475791

ABSTRACT

Granular cell tumour (or Abrikossoff's tumour) was first described by Abrikossoff in 1926. This is a rare benign neoplasm of unclear histogenesis that is generally believed to be of nerve sheath origin. Usually, it presents as a solitary lesion, located mainly in the subcutaneous tissue of the head, or the neck, or in the oral cavity, such as a tongue lesion, although it may develop anywhere in the body. Approximately 1-2% of granular cell tumours are malignant. Granular cell tumours are extremely rare in patients with inflammatory bowel disease. To the best of our knowledge, granular cell tumours have never been reported in association either with Crohn's disease or scheduled infliximab treatment. Herein, we report a case of a granular cell tumour that presented as a subcutaneous skin nodule of the right lumbar area without any associated local or systemic symptoms in a 41-year-old woman with Crohn's disease who was receiving scheduled treatment with infliximab (5 mg/kg every 8 weeks) for 7 years.


Subject(s)
Antibodies, Monoclonal/adverse effects , Crohn Disease/drug therapy , Gastrointestinal Agents/adverse effects , Granular Cell Tumor/chemically induced , Soft Tissue Neoplasms/chemically induced , Adult , Antibodies, Monoclonal/therapeutic use , Female , Gastrointestinal Agents/therapeutic use , Humans , Infliximab , Lumbosacral Region , Tumor Necrosis Factor-alpha/antagonists & inhibitors
5.
Pediatr Radiol ; 38(10): 1134-7, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18679612

ABSTRACT

We present the MR imaging findings in an atypical pulmonary hamartoma in a 12-year-old boy. CT showed no evidence of fat or calcifications in the tumour. It demonstrated peripheral rim enhancement on arterial-phase MR images due to a compressed respiratory epithelium, and progression to nearly homogeneous contrast enhancement on delayed-phase images. Small cystic spaces were identified on MR hydrographic and contrast-enhanced images formed by invaginating respiratory epithelium, a unique imaging finding in this condition.


Subject(s)
Hamartoma/diagnosis , Lung Diseases/diagnosis , Magnetic Resonance Imaging , Child , Contrast Media , Diagnosis, Differential , Hamartoma/pathology , Hamartoma/surgery , Humans , Lung Diseases/pathology , Lung Diseases/surgery , Male , Tomography, X-Ray Computed
7.
JOP ; 7(1): 70-3, 2006 Jan 11.
Article in English | MEDLINE | ID: mdl-16407623

ABSTRACT

CONTEXT: Pancreatic endocrine tumors are unusual tumors arising from cells belonging generically to the amine precursor uptake and decarboxylation system. CASE REPORT: We present a case of a calcitonin-secreting pancreatic endocrine tumor in a 59-year-old male who presented at our Center with elevated calcitonin values. The patient was asymptomatic. Further investigation revealed a tumor, 80 mm in diameter, in the pancreatic body and tail along with three metastatic lesions in segments III, V, and VIII of the liver. Following a distal pancreatectomy, splenectomy and wedge resection of segments III and V along with radiofrequency ablation of the segment VIII lesion, his serum calcitonin reached normal values. CONCLUSIONS: Calcitonin-secreting pancreatic endocrine tumors are often malignant and have a poor prognosis. We believe that an aggressive surgical approach may improve survival.


Subject(s)
Calcitonin/metabolism , Endocrine Gland Neoplasms/metabolism , Pancreatic Neoplasms/metabolism , Calcitonin/blood , Catheter Ablation , Endocrine Gland Neoplasms/blood , Endocrine Gland Neoplasms/secondary , Endocrine Gland Neoplasms/surgery , Humans , Incidental Findings , Liver Neoplasms/diagnosis , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Male , Middle Aged , Pancreas/diagnostic imaging , Pancreas/pathology , Pancreas/surgery , Pancreatic Neoplasms/blood , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms/surgery , Prognosis , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...